MRI/ultrasonography (MRI/US)-fusion biopsy outperforms systematic ultrasonography-guided biopsy, detecting more high-grade prostate tumours while being less able to detect low-grade cancer, thus preventing overtreatment of indolent tumours. Any of several MRI-guided biopsy techniques has the potential, therefore, to replace systematic transrectal ultrasonography-guided prostate biopsies in the future.
- Wendy J. M. van de Ven
- Jelle O. Barentsz
